2013 annual financial data
Iovance Biotherapeutics 2013 Operating margin
Iovance Biotherapeutics 2013 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -22,641,000 USD and net income was -25,381,000 USD.
Operating cash flow was -3,662,192 USD.
Get free Iovance Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -22,641,000 USD
- Net income
- -25,381,000 USD
- Operating cash flow
- -3,662,192 USD